Article
C950T and C1181G osteoprotegerin gene polymorphisms in myeloma bone disease.
Hematology (Amsterdam, Netherlands) - 1 Jun 2014
Sonmez Mehmet, Kazaz Nazlı, Yucel Burcu, Topbas Murat, Ucar Fahri
Abstract excerpt
OBJECTIVES: Bone disease is one of the hallmarks of multiple myeloma (MM). The role of osteoprotegerin (OPG) in the RANK/RANKL/OPG signaling system is well defined in the myeloma bone disease. Polymorphisms of the TNFRSF11B gene encoding OPG have been studied in various bone diseases. However, relationship between the levels of OPG and development of bone lesions regardless of RANKL is yet unknown. In this study,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
